CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 122 enrolled
Drug / intervention
Habit reversal therapy +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00231985
NCT00231985Phase 2Completed

Behavior Therapy and Psychosocial Treatment for Tourette Syndrome and Chronic Tic Disorder

Massachusetts General Hospital·interventional·Posted Oct 4, 2005·Updated Feb 9, 2012

In Brief

A Phase 2 clinical trial evaluating Habit reversal therapy and Supportive therapy for Tourette Syndrome and Tic Disorders. Completed, enrolled 122 participants across 3 sites.

Detailed Summary

This study will compare the efficacy of supportive therapy versus habit-reversal therapy for the treatment of Tourette syndrome and chronic tic disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 4, 2005
Enrollment StartOct 1, 2005
Primary CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 20.7 years ago

Interventions

Habit reversal therapybehavioral

Habit reversal therapy consists of awareness training, relaxation training, self-monitoring, and competing response training.

Supportive therapybehavioral

Supportive therapy focuses on educating participants about tics: how tics present themselves, the causes of tics, the common conditions that may occur along with tics, and environmental factors that may affect their tics (e.g. family, social, school, stress).